FWM
CVS icon

Frontier Wealth Management’s CVS Health CVS Stock Holding History

Frontier Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$1.19M Sell
12,864
-327
-2% -$31.9K 0.09% 162
2022
Q1 		$1.38M Sell
13,191
-8,737
-40% -$918K 0.02% 153
2021
Q4 		$2.26M Buy
21,928
+1,539
+8% +$142K 0.15% 114
2021
Q3 		$1.73M Buy
20,389
+4,327
+27% +$362K 0.12% 130
2021
Q2 		$1.34M Buy
16,062
+186
+1% +$15.2K 0.09% 154
2021
Q1 		$1.19M Buy
15,876
+1,002
+7% +$73K 0.09% 147
2020
Q4 		$1.02M Buy
14,874
+582
+4% +$37.9K 0.08% 156
2020
Q3 		$835K Sell
14,292
-385
-3% -$24K 0.08% 166
2020
Q2 		$954K Sell
14,677
-43,854
-75% -$2.76M 0.09% 148
2020
Q1 		$3.47M Buy
58,531
+40,834
+231% +$2.73M 0.57% 50
2019
Q4 		$1.31M Sell
17,697
-11,872
-40% -$834K 0.21% 105
2019
Q3 		$1.86M Sell
29,569
-119
-0.4% -$7.05K 0.28% 80
2019
Q2 		$1.62M Sell
29,688
-14,385
-33% -$775K 0.24% 85
2019
Q1 		$2.38M Buy
44,073
+1,338
+3% +$82.6K 0.32% 68
2018
Q4 		$2.8M Buy
42,735
+37,106
+659% +$2.77M 0.42% 51
2018
Q3 		$443K Buy
5,629
+735
+15% +$52.5K 0.04% 245
2018
Q2 		$315K Buy
4,894
+439
+10% +$28.9K 0.05% 284
2018
Q1 		$277K Buy
4,455
+225
+5% +$16.1K 0.04% 314
2017
Q4 		$307K Sell
4,230
-2,436
-37% -$177K 0.05% 267
2017
Q3 		$542K Sell
6,666
-7,846
-54% -$621K 0.08% 223
2017
Q2 		$1.17M Sell
14,512
-3,325
-19% -$263K 0.18% 137
2017
Q1 		$1.4M Sell
17,837
-8,550
-32% -$683K 0.21% 120
2016
Q4 		$2.08M Buy
26,387
+10,764
+69% +$871K 0.34% 86
2016
Q3 		$1.39M Buy
15,623
+88
+0.6% +$8.31K 0.21% 115
2016
Q2 		$1.49M Buy
15,535
+3,844
+33% +$383K 0.24% 103
2016
Q1 		$1.21M Buy
11,691
+6,669
+133% +$648K 0.1% 117
2015
Q4 		$491K Sell
5,022
-1,514
-23% -$148K 0.08% 202
2015
Q3 		$631K Buy
6,536
+2,456
+60% +$258K 0.1% 174
2015
Q2 		$428K Buy
4,080
+935
+30% +$95.5K 0.07% 219
2015
Q1 		$325K Buy
+3,145
New +$318K 0.05% 219

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Frontier Wealth Management's CVS Position: Q2 2022 in Review

Frontier Wealth Management reduced its CVS Health (CVS) stake by 2.5% in Q2 2022, selling an estimated $31.9K and leaving 12,864 shares worth $1.19M. The position accounts for 0.09% of the portfolio, ranked #162.

Frontier Wealth Management first reported a position in CVS in Q1 2015 and has held it in 30 quarters since. The position peaked at $3.47M in Q1 2020. 2,310 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

  • Frontier Wealth Management held 12,864 shares of CVS Health worth $1.19M as of Q2 2022.
  • Frontier Wealth Management sold 327 CVS Health shares in Q2 2022, an estimated $31.9K.
  • CVS Health made up 0.09% of Frontier Wealth Management's portfolio in Q2 2022, its #162 holding.
  • Frontier Wealth Management first reported a position in CVS Health in Q1 2015 and has held it in 30 quarters since.
  • Frontier Wealth Management's CVS Health position peaked at $3.47M in Q1 2020.
  • 2,310 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Frontier Wealth Management's 13F filing for Q2 2022, filed 12 Aug 2022.